Satoreotide trizoxetan
- Generic Name
- Satoreotide trizoxetan
- Drug Type
- Small Molecule
- Chemical Formula
- C73H95ClN18O21S2
- CAS Number
- 1638746-88-9
- Unique Ingredient Identifier
- 3M7TX701A4
Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2)
Phase 1
Terminated
- Conditions
- Small Cell Lung Cancer and Breast Cancer
- Interventions
- First Posted Date
- 2018-12-12
- Last Posted Date
- 2022-09-13
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 9
- Registration Number
- NCT03773133
- Locations
- 🇫🇷
CHU de Marseille - Hôpital la Timone, Marseille, France
🇩🇪Universitaetsklinikum Essen, Essen, Germany
🇨ðŸ‡University Hospital Basel, Basel, Switzerland
Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer
- First Posted Date
- 2018-10-05
- Last Posted Date
- 2020-09-07
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 4
- Registration Number
- NCT03697551
- Locations
- 🇦🇹
Medical University Innsbruck, Innsbruck, Austria
68Ga-OPS202 Study for Diagnostic Imaging of GEP NET
Phase 1
Completed
- Conditions
- Gastroenteropancreatic Neuroendocrine Tumors
- Interventions
- First Posted Date
- 2014-06-12
- Last Posted Date
- 2019-10-02
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 12
- Registration Number
- NCT02162446
- Locations
- 🇨ðŸ‡
University Hospital Basel, Basel, Switzerland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath